CAS: 107233-08-9; Cis-2-Methyl-1'-Azaspiro[[1,3]Oxathiolane-5,3'-Bicyclo[2.2.2]Octane]

该化合物是一个有选择地针对肌肉受体,特别是M1和M3子型的胆碱基抗体的胆碱基抗体,主要用于治疗与Sjögren综合症有关的Xerotomi(干嘴),因为它能刺激口腔和拉皮尔腺分泌. 复合体的口服生物利用率高,而且具有有利的药用植物特征,确保了持续的治疗效果. 它的行动机制包括加强外科腺功能,而没有重大的系统副作用,使它成为治疗症状的可靠选择. 谢米林在管理秘密功能方面的特性和功效凸显了它在自动免疫及相关条件下的临床效用.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      专利信息


      专利号:US-9751877-B2
      优先权日:2012-09-21
      标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
      发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
      权利人:PFIZER
      摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

      专利号:US-2023271983-A1
      优先权日:2020-07-29
      标题 :Functionalized isonitriles and products, preparation and uses thereof
      发明人:SOTELO PÉREZ EDDY; AZUAJE GUERRERO JHONNY ALBERTO; MAJELLARO MARIA
      权利人:UNIV SANTIAGO COMPOSTELA
      摘要:The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorophore molecules. The invention also relates to conjugates between said isonitrile compounds and functional molecules, which are useful in the synthesis of pharmaceutic drugs or tools, fluorescent molecules and labels, polymeric smart materials. The invention furthermore provides a kit for the in-vitro preparation of the functionalized isontrile compounds and conjugates. The invention also contemplates the medical use of said compounds and conjugates.

      专利号:WO-2025030095-A1
      优先权日:2023-08-03
      标 题 :Methods of synthesis
      发明人:DERSTINE BRENDEN PAUL; TUCKER JOHN LLOYD
      权利人:NEUROCRINE BIOSCIENCES INC
      摘要:This present disclosure relates to processes for preparing a compound of Formula (A) which is useful as an intermediate in the preparation of mAChR agonist compounds; and compositions comprising the compound of Formula (A).

      专利号:US-9550795-B2
      优先权日:2011-08-31
      标 题:Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
      发明人:BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS
      权利人:BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS; PFIZER
      摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

      专利号:WO-2012172449-A1
      优先权日:2011-06-13
      标题:Lactams as beta secretase inhibitors
      发明人:BRODNEY MICHAEL AARON
      权利人:PFIZER; BRODNEY MICHAEL AARON
      摘要:Compound and pharmaceutically acceptable salts of the compound are disclosed, wherein the compound has the structure (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. The compound of formula I is useful as beta secretase inhibitor for use in the treatment of Alzheimer's and other neurodegenerative and/or neurological disorders.

      专利号:US-2016229847-A1
      优先权日:2013-10-04
      标 题:Novel bicyclic pyridinones as gamma-secretase modulators
      发明人:PETTERSSON MARTIN YOUNGJIN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; JOHNSON DOUGLAS SCOTT; KAUFFMAN GREGORY WAYNE; O'DONNELL CHRISTOPHER WILLIAM; PATEL NANDINI CHATURBHAI; STEPAN ANTONIA FRIEDERIKE; STIFF CORY MICHAEL; SUBRAMANYAM CHAKRAPANI; TRAN TUAN PHONG; VERHOEST PATRICK ROBERT
      权利人:PFIZER
      摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula II as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Barbe AG. Long-term Use of the Sialogogue Medications Pilocarpine and Cevimeline Can Reduce Xerostomia Symptoms and Increase Salivary Flow in Head and Neck Cancer Survivors After Radiotherapy. J Evid Based Dent Pract. 2017 Sep;17(3):268-270. doi: 10.1016/j.jebdp.2017.06.013. Epub 2017 Jul 3. doi: 10.1016/j.autneu.2017.05.010. Epub 2017 May 30.

      合成参考文献


      摘要:Physicians Desk Reference. 58th ed. Thomson PDR. Montvale, NJ 2004., p. 1183
      摘要:Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004., p. 792
      摘要:Cowl, C.T. Physician's Handbook 10th edition. Lippincott Williams & Wilkins, Philadelphia, PA. 2003, p. 294
      参考文献:10.1016/s0049-0172(99)80001-8
      摘要:Anaya JM, Talal N. Sjögren's syndrome comes of age. Semin Arthritis Rheum. 1999 Jun;28(6):355–9. doi: 10.1016/s0049-0172(99)80001-8.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知